Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-08-30

Clinical Trial Update: European Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in Pemphigus [Phase 2, Phase 3]

View source ↗

Summary

European Phase 2/3 trial of adjuvant oral glucocorticoid pulse therapy for pemphigus has completed; no results are summarized in the document.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHYLPREDNISOLONE (methylprednisolone)
  • PREDNISONE (Prednisone)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Pemphigus | Phase 2, Phase 3 | Status: COMPLETED